The CBF have taken delivery of another batch of GSK's ChAd3-EBO Z vaccine and also imported the MVA-EBO Z vaccine manufactured at Emergent Biosolutions (US). Both vaccines were QP certified to trial at the CBF and are currently evaluated by Prof Adrian Hill in a Phase I trial in Oxford.

Further trials using these and other vaccines (all to be QP certified at the CBF) are in the pipeline in the UK and Africa.

See also updates on Ebola Research at the Nuffield Department of Medicine.

Ebola virus
Ebola virus